Log in to save to my catalogue

Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosi...

Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosi...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4d7b1e9a5d4e4159a4d6013b32f028d5

Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis

About this item

Full title

Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis

Publisher

England: BioMed Central Ltd

Journal title

Molecular neurodegeneration, 2018-11, Vol.13 (1), p.60-60, Article 60

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

It is unclear to what extent pre-clinical studies in genetically homogeneous animal models of amyotrophic lateral sclerosis (ALS), an invariably fatal neurodegenerative disorder, can be informative of human pathology. The disease modifying effects in animal models of most therapeutic compounds have not been reproduced in patients. To advance therap...

Alternative Titles

Full title

Tissue-enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4d7b1e9a5d4e4159a4d6013b32f028d5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4d7b1e9a5d4e4159a4d6013b32f028d5

Other Identifiers

ISSN

1750-1326

E-ISSN

1750-1326

DOI

10.1186/s13024-018-0292-2

How to access this item